Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Clorox Co    CLX

Delayed Quote. Delayed  - 07/29 10:01:28 pm
131.07 USD   +0.18%
07/25 CLOROX CO : ex-dividend day
07/20 THE CLOROX COMP : Partners with DonorsChoose.org to provide $100,000..
07/18 CLOROX : Liquid Plumr bottles recalled for faulty child-resistant cl..
News SummaryMost relevantAll newsSector news 

The Clorox Company : Refutes Silent Spring Institute's Study on Our Consumer Products

share with twitter share with LinkedIn share with facebook
share via e-mail
03/08/2012 | 03:26pm CEST

We have reviewed the findings of Silent Spring's study claiming some U.S. consumer products contain endocrine-disrupting and asthma-related ingredients.

Product safety is a top priority at The Clorox Company and our company guidelines prohibit using endocrine-disrupting ingredients in our products. For those household products containing fragrance ingredients some consider to be asthma related, these ingredients are present at such low concentrations they do not cause irritation or trigger asthma when used as directed.

Our highly skilled scientists evaluate each product's safety, efficacy and regulatory compliance before it makes it to store shelves. Our safety assessments begin with analysis of each of the materials that go into making the product. This includes consideration of short-term and long-term impact from all types of exposures, including incidental or accidental, and routes of exposure such as skin, eye, ingestion and inhalation. Our safety evaluation also includes the assessment of fragrances, dyes, and preservatives, and other proprietary ingredients, in our formulations.

Clorox voluntarily discloses all ingredients for our U.S. and Canadian household cleaning and disinfecting products through our industry-leading initiative, Ingredients Inside (www.IngredientsInside.com), which is available on our corporate web site and mobile platforms.

For more information on our product stewardship guidelines, visit http://www.thecloroxcompany..

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on CLOROX CO
07/25 CLOROX CO : ex-dividend day
07/20 THE CLOROX COMPANY : Partners with DonorsChoose.org to provide $100,000 to schoo..
07/18 CLOROX : Liquid Plumr bottles recalled for faulty child-resistant closures
07/18 HEALTH HIGHLIGHTS : July 18, 2016
07/06 Goldman Sachs, Halliburton and Delta fall; Clorox climbs
07/01DJAmazon's Alexa Now Lets You Order Tens of Millions of Products With Your Voic..
06/30 CLOROX : Announces Aug. 3 Webcast of Fourth-Quarter and Fiscal Year 2016 Results
06/09 CLOROX : Hannah Simone And Fresh Step® With The Power Of Febreze™ Surprise..
06/09 CLOROX : Hannah Simone And Fresh Step® With The Power Of Febreze(TM) Surprise Ne..
05/25 CLOROX : Announces June 15 Webcast of Company Presentation at dbAccess Global Co..
More news
Sector news : Household Products - NEC
07/29DJNEWELL BRANDS : Earnings Top Views
07/29DJRECKITT BENCKISER : Reports 18.5% Drop in First Half Profit
07/29DJRECKITT BENCKISER : Reports 18.5% Drop in First Half Profit
07/29 RECKITT BENCKISER : outlook hurt by Korean sanitiser issue
07/29DJRECKITT BENCKISER : Pretax Profit Down 19%
More sector news : Household Products - NEC
News from SeekingAlpha
07/27 Finding Some Of The Best-Quality Dividend Growth Stocks Using The Piotroski F..
07/25 The Strong Often Get Stronger!
07/25 RETIREMENT : Here We Go, Transitioning To The Distribution Phase - First Six Mon..
07/22 6 MONTH PORTFOLIO UPDATE : Good News, Double-Digit Increase In Both Income And V..
07/21 CONSUMER STAPLES : Finding Value In An Expensive Sector
Financials ($)
Sales 2016 5 750 M
EBIT 2016 1 074 M
Net income 2016 649 M
Debt 2016 1 807 M
Yield 2016 2,36%
P/E ratio 2016 26,57
P/E ratio 2017 25,10
EV / Sales 2016 3,26x
EV / Sales 2017 3,11x
Capitalization 16 922 M
More Financials
Duration : Period :
Clorox Co Technical Analysis Chart | CLX | US1890541097 | 4-Traders
Full-screen chart
Technical analysis trends CLOROX CO
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus HOLD
Number of Analysts 15
Average target price 126 $
Spread / Average Target -3,8%
Consensus details
EPS Revisions
More Estimates Revisions
Benno O. Dorer Chief Executive Officer & Director
George J. Harad Independent Chairman
Stephen M. Robb Chief Financial Officer & Executive Vice President
James E. Foster EVP-Information Technology & Product Supply
Robert W. Matschullat Lead Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CLOROX CO3.15%16 922
CHURCH & DWIGHT CO., I..16.06%12 642
LION CORP38.40%4 437
More Results